Skip to main content
Premium Trial:

Request an Annual Quote

Technical Difficulties

ABC News Online of Australia reports that the National Health and Medical Research Council has pushed back their application deadlines to March 22, following complications with its online grants system. Researchers who are having difficulties with the system described it as "slow" and clearly "under stress, " to Emily Bourke at ABC. Last week, the NHMRC sent e-mails to researchers to apologize for the glitches in the system. Warwick Anderson, chief executive of the council, told ABC: "We have put in place a number of temporary fixes to try and ease the load on the community out there." She adds, "We have guaranteed to the researchers that we will not close off any application that people are making to us until they have successfully completed the application." Anderson also says that the council is unsure why the technical problems have occurred, but touted the new online system, saying "I think we all realize that this is actually, in the long run, going to be very good. ... We've got great faith in the system as the medical research community will work through this and work it out."

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.